Find practical information about diabetes treatment and management, including blood sugar monitoring, medications, lifestyle changes, complications and everyday diabetes care.
Biomae Fusion has completed patient enrolment in its phase II trial of icovamenib, a potential breakthrough in insulin-deficient type 2 diabetes, with results now expected in early 2027, signalling a significant step forward for the experimental drug. Biomae Fusion said…
Eli Lilly’s Foundayo, the first approved once-daily GLP-1 tablet in Europe, is now available in UK pharmacies, offering a new oral treatment option for weight management and diabetes control, potentially expanding access for patients unable to use injectable medicines. A…
A small University of Illinois Chicago trial indicates that limiting eating to an eight-hour window may help some adults with type 1 diabetes improve blood glucose management safely, sparking cautious optimism for wider application. A small clinical trial from the…
Irregular sleep, meal timing, and alcohol consumption during weekends can have lasting effects on blood sugar control, emphasizing the importance of consistency for metabolic health even in healthy adults. Weekends may feel like a harmless pause from routine, but the…
A new weekly insulin pen for type 2 diabetes is close to NHS approval, promising to dramatically reduce daily injections and improve treatment adherence for vulnerable patients, with potential to reshape diabetes care routines. A once-weekly insulin pen for type…
Google expands the role of its Pixel Watch 5, introducing innovative trend-based health tools for blood pressure, insulin resistance, and breathing, shifting wearables from passive fitness gadgets to proactive health monitors that identify physiological shifts over time. Google is widening…
Medical experts emphasise the importance of sticking to water-only intake before taking oral GLP-1 weight-loss medicines, warning that coffee and other drinks may impair absorption and cause discomfort. People taking oral GLP-1 weight-loss medicines are being told not to wash…
A nurse-led educational programme using plain language and teach-back methods significantly enhances understanding and self-management of diabetes among uninsured Hispanic adults, reducing communication barriers in a non-profit mobile clinic setting. Health literacy is more than the ability to read medical…
Two recent Epic Research studies reveal that adults experiencing significant weight loss during their first year on GLP-1 therapies are likely to retain these gains into a second year, with sustained benefits more common among those without diabetes and influenced…
A specialist highlights that obesity injections like semaglutide may also help preserve kidney function in type 2 diabetes sufferers, with recent clinical trial data supporting its potential beyond weight loss. A diabetes and kidney specialist is urging patients not to…
A study from a Wenzhou eye hospital identifies three distinct profiles among Chinese adults with diabetic retinopathy, highlighting opportunities for personalised treatment and improved outcomes across different socio-economic groups. A new study from a tertiary eye hospital in Wenzhou, China,…
Updated obstetric and endocrinology guidance recommends women on GLP-1 therapies to work closely with clinicians to schedule medication discontinuation before pregnancy, reflecting evolving understanding of safety and metabolic management. Women taking GLP-1 medicines and hoping to conceive are being urged…
